Phase I-IIa trials
- bioequivalence and bioavailability studies
- first in man and dose escalation studies
- drug-drug interaction and food-drug interaction studies
- studies in special populations
- studies using special methods like endoscopy
- patient recruitment in various indications
Performance of studies is supported by significant in-depth experience gained over many years, assuring low variability and reliable results.